Literature DB >> 24003035

Dietary fibre concentrate from Chilean algarrobo (Prosopis chilensis (Mol.) Stuntz) pods: purification and characterization.

Ana María Estévez1, Fernando Figuerola2, Enrique Bernuy3, Carmen Sáenz3.   

Abstract

Prosopis species are generally fast-growing, drought-resistant, nitrogen-fixing trees or shrubs. Fruits of Prosopis spp are indehiscent pods, where pericarp is formed by the epicarp, light brown in colour, and fibrous nature; the mesocarp known as pulp, which is rich in sugars; and the endocarp. The aim of this work was to obtain a fibre concentrate from the pods of Prosopis chilensis Mol. (Stuntz) and to determine the chemical, physical, and technological properties of the pod flour (PF) and of a fibre concentrate or pod purified flour (PPF). Acetone, ethanol, and water at different conditions of time and temperature were used in the purification process. PF showed 53.7 g/100 g of total sugar content, 4.2 g/100 g of reducing sugar content, 41.8 g/100 g of total dietary fibre, 35.8 g/100 g of insoluble fibre, and 6.0 g/100 g of soluble fibre content. The PPF has a total sugar content of 3.8 g/100 g, reducing sugar content of 2.2 g/100 g, total dietary fibre content of 80.8 g/100 g, insoluble fibre content of 75.1 g/100 g, and soluble fibre content of 5.7 g/100 g. The scanning electron microscopy analysis showed the existence of voids in the structure of PPF flour, which reveals the efficiency of the purification process with a high decrease in the total sugar content.
© The Author(s) 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Dietary fibre; food ingredients; physical properties

Mesh:

Year:  2013        PMID: 24003035     DOI: 10.1177/1082013213499769

Source DB:  PubMed          Journal:  Food Sci Technol Int        ISSN: 1082-0132            Impact factor:   2.023


  1 in total

Review 1.  Current Insights into Phytochemistry, Nutritional, and Pharmacological Properties of Prosopis Plants.

Authors:  Jianshu Zhong; Peiyao Lu; Hanjing Wu; Ziyao Liu; Javad Sharifi-Rad; William N Setzer; Hafiz A R Suleria
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-11       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.